The Panel's First Claims
Max Lugavere introduces Dr. Florence Kate without asking what a longevity panel actually measures. Dr. Franklin links blood type to neurological vulnerability, while Dr. Daniel Hayes offers a soybean enzyme and a 36 percent clotting factor reduction. Zetterberg's Lancet Healthy Longevity work shows blood biomarkers can screen for neurodegenerative dementias, but it does not make blood type a death forecast.






